Capital gains
Imperial students win big at Mayor’s entrepreneurship competition
Three out of four of this year’s Mayor’s Entrepreneur Programme awards were given to Imperial student teams.
Stories tagged with 'enterprise'
London innovators
Imperial and LSE showcase student startups
Over 25 startups from two of London’s leading universities, Imperial College London and LSE, pitched their business ideas at a virtual demo day.
Zero Pollution Launch
Re-design the future, Mary Robinson urges at Transition to Zero Pollution launch
Mary Robinson, former President of Ireland, called for “a bold new vision for the future” at the launch of Transition to Zero Pollution.
Wear and tear
Tackling harmful tyre emissions: student inventors win Dyson Award
A group of Imperial students have won this year’s James Dyson Award for their device to curb microplastic emissions from vehicle tyres.
Physiotherapy progress
Physiotherapy 'gaming' platform could help patient recovery
An Imperial medical student has created a new platform that gamifies physiotherapy and helps patients to recover.
Enterprising activity
Industry collaboration and entrepreneurship reach new heights
Imperial is using its world-leading academic expertise to address real-world challenges through industry partnerships and entrepreneurship.
Nature-inspired
Next-generation cast inspired by animal scales could protect against injuries
An Imperial graduate has designed wearable technology inspired by protective structures found in the animal world to protect athletes from injury.
Student enterprise
Q&A with Imperial student start-up Synthesea
Synthesea is an Imperial student-led start-up that aims to develop cheap, sustainable lipid synthesis tools.
Eco Incubator Startups
Sustainability startups join the Imperial White City Incubator
A cluster of startups has joined the Imperial Incubator community to advance their technologies for renewable energy and sustainable food industries.
COVID-19 drug trial
New trial to test anti-inflammatory drugs in patients with COVID-19 pneumonia
Drugs used to reduce the body’s inflammatory response will be trialled in hospitalized patients with COVID-19 pneumonia
